THE CBR INSTITUTE FOR BIOMEDICAL RESEARCH, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
  
 
C07K PEPTIDES 2134
 
  
 
C12M APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY 148
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8247185 Conformation specific antibodiesMar 08, 11Aug 21, 12[A61K, C12Q]
7927591 Conformation specific antibodiesFeb 22, 05Apr 19, 11[A61K, C07K]
7825088 Methods for the treatment of multiple myelomaApr 24, 06Nov 02, 10[A61K]
7615211 CD70 inhibition for the treatment and prevention of inflammatory bowel diseaseFeb 08, 05Nov 10, 09[A61K]
7271152 Compounds and methods for the modulation of CD154May 03, 02Sep 18, 07[A61K]
7084241 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseasesJan 31, 02Aug 01, 06[C07K]
7078044 Anti-amoebic vaccineOct 03, 02Jul 18, 06[A61K]
6861504 Compounds and methods for the modulation of CD154Nov 30, 01Mar 01, 05[A61K]
5612207 Method and apparatus for encapsulation of biologically-active substances in cellsDec 18, 95Mar 18, 97[C12N, C12M]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2009/0142,355 DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETESAbandonedApr 30, 08Jun 04, 09[A61K, C12Q, C40B]
2008/0153,764 System and Methods For Short Rna ExpressionAbandonedJan 21, 05Jun 26, 08[A61K, C07H, C12Q, C12N, A01K, A61P]
2007/0274,915 Modulation Of Anergy And Methods For isolating Anergy-Modulating CompoundsAbandonedMar 29, 04Nov 29, 07[A61K, C12Q, C12N]
2007/0240,991 Gelling Electrophoresis Loading BufferAbandonedJun 27, 05Oct 18, 07[G01N]
2007/0042,403 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseasesAbandonedJun 23, 06Feb 22, 07[A61K, C07H, C12Q, C12P, G01N, C07K]
2006/0263,340 Treating gastrointestinal diseases with modulators of retinoic acidAbandonedApr 28, 06Nov 23, 06[A61K, C12N]
2006/0142,187 Methods for modulating cell-to-cell adhesion using an agonist of C1INH-type protein activityAbandonedNov 14, 05Jun 29, 06[A61K]
2006/0019,951 VacuolinsAbandonedDec 23, 04Jan 26, 06[A61K, C07D]
2005/0288,218 Methods for treating and preventing sepsis using modified C1 inhibitor or fragments thereofAbandonedMar 24, 05Dec 29, 05[A61K]
6929792 Modified dendritic cells and use thereforExpiredMar 31, 00Aug 16, 05[A61K, A01N, C12N]
6921637 Colloid compositions for solid phase biomolecular analytical, preparative and identification systemsExpiredMay 04, 01Jul 26, 05[G01N]
2005/0019,743 Compounds and methods for improving platelet recovery and functionAbandonedMay 21, 04Jan 27, 05[A01N]
6797819 AlkaloidsExpiredMay 22, 01Sep 28, 04[C07D]
2004/0002,117 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseasesAbandonedFeb 04, 03Jan 01, 04[A61K, G01N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.